Literature DB >> 1642658

Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation.

A M Irani1, B L Gruber, L D Kaufman, M B Kahaleh, L B Schwartz.   

Abstract

OBJECTIVE: To analyze the concentration and distribution of the MCT (tryptase-positive, chymase-negative) and MCTC (tryptase-positive, chymase-positive) types of mast cell in cutaneous lesions of scleroderma.
METHODS: Biopsy specimens were obtained from skin lesions in 24 patients with scleroderma, and subjected to double immunohistochemical analysis using mouse monoclonal anti-tryptase and anti-chymase antibodies.
RESULTS: Dermal mast cell concentrations were below the normal range in 12 of the specimens, most of which were obtained between 1 and 4 years after disease onset. All other specimens contained normal concentrations of mast cells. MCT cells were present in 12 specimens and comprised between 8% and 100% of the total mast cells. Extracellular tissue deposits of tryptase-positive and/or chymase-positive granular material were observed in 8 specimens, suggesting possible mast cell degranulation.
CONCLUSION: These findings are in contrast to those in normal skin, where MCTC cells are essentially the only type of mast cell present in the dermis. The results suggest that mast cells are involved in the pathogenesis of cutaneous lesions in scleroderma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642658     DOI: 10.1002/art.1780350813

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

1.  Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration.

Authors:  A Orfao; L Escribano; J Villarrubia; J L Velasco; C Cerveró; J Ciudad; J L Navarro; J F San Miguel
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 2.  The Importance of Mast Cells in Dermal Scarring.

Authors:  Traci A Wilgus; Brian C Wulff
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-04-01       Impact factor: 4.730

Review 3.  Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions.

Authors:  Michael J Monument; David A Hart; Paul T Salo; A Dean Befus; Kevin A Hildebrand
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

4.  Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor.

Authors:  R J Blair; H Meng; M J Marchese; S Ren; L B Schwartz; M G Tonnesen; B L Gruber
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

Review 5.  Mast cells and immunological skin diseases.

Authors:  Daniel Navi; Jun Saegusa; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

Review 6.  Mast cell proteinases and cytokines in skin inflammation.

Authors:  I T Harvima; L Horsmanheimo; A Naukkarinen; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

7.  Mast cells as a target in the treatment of rheumatoid arthritis.

Authors:  O Bakharevski; P F Ryan
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

8.  Synovial mast cell responses during clinical improvement in early rheumatoid arthritis.

Authors:  I Gotis-Graham; M D Smith; A Parker; H P McNeil
Journal:  Ann Rheum Dis       Date:  1998-11       Impact factor: 19.103

9.  The role of macrophage migration inhibitory factor in mast cell-stimulated fibroblast proliferation and collagen production.

Authors:  Gu Ningyan; Yao Xu; Shi Hongfei; Chen Jingjing; Chen Min
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

10.  Mast cell-specific Cre/loxP-mediated recombination in vivo.

Authors:  Julia Scholten; Karin Hartmann; Alexander Gerbaulet; Thomas Krieg; Werner Müller; Giuseppe Testa; Axel Roers
Journal:  Transgenic Res       Date:  2007-10-31       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.